167 related articles for article (PubMed ID: 2889459)
1. Peripheral vascular effects of beta-adrenoceptor blockade: comparison of two agents.
Cooke ED; Maltz MB; Smith RE; Bowcock SA; Watkins CJ; Camm AJ
Br J Clin Pharmacol; 1987 Sep; 24(3):359-66. PubMed ID: 2889459
[TBL] [Abstract][Full Text] [Related]
2. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
3. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
4. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
[TBL] [Abstract][Full Text] [Related]
5. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
7. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.
Pringle TH; Riddell JG; Shanks RG
Eur J Clin Pharmacol; 1988; 35(5):507-14. PubMed ID: 2853055
[TBL] [Abstract][Full Text] [Related]
9. The use of Doppler ultrasound techniques to study the effects of isoprenaline and beta-adrenoceptor blocking drugs on peripheral blood vessels in man.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1984 Jun; 17(6):773-6. PubMed ID: 6146331
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of the beta 1-selectivity of single doses of bisoprolol and atenolol.
Chang PC; van Veen S; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S58-60. PubMed ID: 2439799
[TBL] [Abstract][Full Text] [Related]
11. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
[TBL] [Abstract][Full Text] [Related]
12. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Arnold JM; O'Connor PC; Riddell JG; Harron DW; Shanks RG; McDevitt DG
Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
Lundgren B; Carlsson E; Herrmann I
Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
[TBL] [Abstract][Full Text] [Related]
14. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
McGibney D; Singleton W; Silke B; Taylor SH
Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
[TBL] [Abstract][Full Text] [Related]
15. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Hansen O; Johansson BW; Nilsson-Ehle P
Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of bevantolol hydrochloride, a beta 1-adrenoceptor antagonist, in asthmatic patients.
Löfdahl CG; Svedmyr K; Svedmyr N
Pharmacotherapy; 1984; 4(4):205-10. PubMed ID: 6148733
[TBL] [Abstract][Full Text] [Related]
17. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
Pringle TH; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
[TBL] [Abstract][Full Text] [Related]
19. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
[TBL] [Abstract][Full Text] [Related]
20. Ventilatory effects of atenolol and bevantolol in asthma.
Lammers JW; Folgering HT; van Herwaarden CL
Clin Pharmacol Ther; 1985 Oct; 38(4):428-33. PubMed ID: 4042527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
